The National Institutes of Health (NIH) is a critical pillar of the U.S. public health system and a beacon of guidance for healthcare best practices across the globe. This has never been more evident than during the COVID-19 crisis. A lesser-known NIH facet is its long and productive history of technology transfer success.
TTC is planning a technology opportunities webinar on July 13, 2021 from 11:00 am – noon, EST. Attendees will hear from the NCI’s Dr. Genoveffa Franchini about a new HIV [….]
NCI Technology Opportunities Webinar: “Complete Tumor Regression Seen in Colon Cancer and Leukemia Animal Models with a Novel High Efficacy Fluorinated Cytidine Therapeutic Compound”
The National Cancer Institute (NCI), Technology Transfer Center (TTC) will host a webinar to highlight a cancer therapeutic technology for collaborative development and/or licensing. The webinar presented by the technology inventor, Dr. Joel Morris, will highlight NCI’s novel, therapeutic fluorinated cytidine compound that shows high efficacy against colon cancer and leukemia. Studies indicated that the therapeutic compound can produce complete regression in xenograph mouse models with minimal effects on body weight. Registration is free.
Griffin St Louis Joins TEDCO as Program Manager, Maryland Innovation Initiative (MII)
5 Questions with Dan Gincel, PhD, Executive Director, MD Stem Cell Research Fund at TEDCO “5 Questions With……” is a weekly BioBuzz series where we reach out to interesting people [….]
The 2nd Annual Tech Showcase Reflects New Culture at NCI & FNLCR When you hear the term “government research” do the words “entrepreneur”, “start-up”, “commercially relevant” or “industry partner” come to [….]
New Director of TEDCO’s University Commercialization Fund Shares Vision for the Future The Maryland Innovation Initiative (MII) is the State’s premier $5.8M investment program for validating and commercializing University research [….]